Title of Invention

"A PHARMACEUTICAL COMPOSITION FOR ALTERING THE AFFINITY OF A NUCLEIC ACID LIGAND FOR A COAGULATION FACTOR IN A MAMMALIAN HOST"

Abstract The biological activity of nucleic acid ligand is regulated (i.e. enhanced or inhibited) in vivo to produce a desired biological effect. This is accomplished through the administration of a modulator, or regulator, that changes the binding of the nucleic acid ligand for its target or that degrades or otherwise cleaves, metabolizes or breaks down the nucleic acid ligand while the ligand is still exerting its effect. Modulators of the present invention can be administered in real time as needed based on various factors, including the progress of the patient, as well as the physicians discretion in how to achieve optimal therapy. Thus, this invention provides for the first time a regulatable therapeutic regime in the course of nucleic acid ligand therapy.
Full Text

Documents:

3071-DELNP-2008 (Petition) AA.pdf

3071-delnp-2008-1-Correspondence Others-(21-01-2014).pdf

3071-delnp-2008-1-Correspondence Others-(21-01-2014).tif

3071-delnp-2008-1-Drawings-(21-01-2014).pdf

3071-delnp-2008-Abstract-(21-01-2014).pdf

3071-delnp-2008-abstract.pdf

3071-delnp-2008-Assignment-(21-01-2014).pdf

3071-delnp-2008-assignment.pdf

3071-delnp-2008-Assingment-(12-02-2014).pdf

3071-delnp-2008-Claims-(20-08-2014).pdf

3071-delnp-2008-Claims-(21-01-2014).pdf

3071-delnp-2008-claims.pdf

3071-delnp-2008-Correspondence Others-(02-07-2014).pdf

3071-delnp-2008-Correspondence Others-(12-02-2014).pdf

3071-delnp-2008-Correspondence Others-(15-01-2014).pdf

3071-delnp-2008-Correspondence Others-(20-08-2014).pdf

3071-delnp-2008-Correspondence Others-(21-01-2014).pdf

3071-delnp-2008-Correspondence Others-(22-01-2014).pdf

3071-delnp-2008-Correspondence-others (03-10-2008).pdf

3071-delnp-2008-Correspondence-others (15-09-2008).pdf

3071-delnp-2008-Correspondence-Others-(23-08-2013).pdf

3071-delnp-2008-Correspondence-Others-1-(21-01-2014).pdf

3071-delnp-2008-correspondence-others.pdf

3071-delnp-2008-description (complete).pdf

3071-delnp-2008-Drawings-(15-04-2008).pdf

3071-delnp-2008-Form-1-(21-01-2014).pdf

3071-delnp-2008-form-1.pdf

3071-delnp-2008-Form-13-(21-01-2014).pdf

3071-delnp-2008-Form-18 (03-10-2008).pdf

3071-delnp-2008-Form-2-(21-01-2014).pdf

3071-delnp-2008-form-2.pdf

3071-delnp-2008-Form-3 (15-09-2008).pdf

3071-delnp-2008-Form-3-(15-01-2014).pdf

3071-delnp-2008-Form-3-(23-08-2013).pdf

3071-delnp-2008-form-3.pdf

3071-delnp-2008-form-5.pdf

3071-delnp-2008-GPA (03-10-2008).pdf

3071-delnp-2008-Petition-137-(22-01-2014).pdf


Patent Number 265868
Indian Patent Application Number 3071/DELNP/2008
PG Journal Number 13/2015
Publication Date 27-Mar-2015
Grant Date 20-Mar-2015
Date of Filing 15-Apr-2008
Name of Patentee DUKE UNIVERSITY
Applicant Address OFFICE OF SCIENCE AND TECHNOLOGY P.O. BOX 90083 DURHAM, NC 27708-0083, USA.
Inventors:
# Inventor's Name Inventor's Address
1 SULLENGER, BRUCE, A ST. ANDREWS COURT, DURHAM, NC 27707, KUA.
2 RUSCONI, CHRISTOPHER 1429 PENNSYLVANIA AVENUE, DURHAM, NC 27705,USA.
PCT International Classification Number NA
PCT International Application Number PCT/US02/16555
PCT International Filing date 2002-05-28
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 60/293,231 2001-05-25 U.S.A.
2 60/331,037 2001-11-07 U.S.A.